| id | C00037771 |
|---|---|
| Name | S-Allylcysteine |
| CAS RN | 21593-77-1 |
| Standard InChI | InChI=1S/C6H11NO2S/c1-2-3-10-4-5(7)6(8)9/h2,5H,1,3-4,7H2,(H,8,9)/t5-/m0/s1 |
| Standard InChI (Main Layer) | InChI=1S/C6H11NO2S/c1-2-3-10-4-5(7)6(8)9/h2,5H,1,3-4,7H2,(H,8,9) |
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 6469 |
| By standard InChI | CHEMBL2048654 |
|---|---|
| By standard InChI Main Layer | CHEMBL1592541 CHEMBL2048654 |
| By LinkDB | C16759 |
|---|
| By CAS RN | C065299 |
|---|
| class name | count |
|---|---|
| Liliopsida | 1 |
| family name | count |
|---|---|
| Amaryllidaceae | 1 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Allium tuberosum Rottl.ex Spreng. | 4678 | Amaryllidaceae | Liliopsida | Viridiplantae |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL1592541 |
CHEMBL1614458
(1)
|
0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1592541 |
CHEMBL1613914
(1)
|
0 / 0 |
| P37088 | Amiloride-sensitive sodium channel subunit alpha | NA | CHEMBL2048654 |
CHEMBL2051232
(1)
|
2 / 2 |
| P51168 | Amiloride-sensitive sodium channel subunit beta | Unclassified protein | CHEMBL2048654 |
CHEMBL2051232
(1)
|
3 / 3 |
| P51170 | Amiloride-sensitive sodium channel subunit gamma | Unclassified protein | CHEMBL2048654 |
CHEMBL2051232
(1)
|
2 / 3 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C065299 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | S-allylcysteine results in decreased expression of BCL2 protein |
decreases expression
|
protein |
17155983
|
| C065299 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | S-allylcysteine results in increased cleavage of CASP3 protein |
increases cleavage
|
protein |
17155983
|
| C065299 | 999 |
CDH1
Arc-1 CD324 CDHE ECAD LCAM UVO |
cadherin 1, type 1, E-cadherin (epithelial) | S-allylcysteine results in increased expression of CDH1 protein |
increases expression
|
protein |
17155983
|
| C065299 | 3728 |
JUP
ARVD12 CTNNG DP3 DPIII PDGB PKGB |
junction plakoglobin | S-allylcysteine results in increased expression of JUP protein |
increases expression
|
protein |
17155983
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #211400 | Bronchiectasis with or without elevated sweat chloride 1; besc1 |
P51168
|
| #613021 | Bronchiectasis with or without elevated sweat chloride 2; besc2 |
P37088
|
| #613071 | Bronchiectasis with or without elevated sweat chloride 3; besc3 |
P51170
|
| #177200 | Liddle syndrome |
P51168
P51170 |
| #264350 | Pseudohypoaldosteronism, type i, autosomal recessive; pha1b |
P37088
P51168 |
| KEGG | disease name | UniProt |
|---|---|---|
| H00243 | Hyperkalemic distal renal tubular acidosis (RTA type 4) |
P37088
(related)
P51168 (related) P51170 (related) |
| H00892 | Bronchiectasis with or without elevated sweat chloride |
P37088
(related)
P51168 (related) P51170 (related) |
| H00242 | Liddle syndrome |
P51168
(related)
P51170 (related) |
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D003921 | C065299 | Diabetes Mellitus, Experimental |
therapeutic
|
20951120
|
|
| D006331 | C065299 | Heart Diseases |
therapeutic
|
17182065
|
|
| D009203 | C065299 | Myocardial Infarction |
therapeutic
|
16757080
19067678 |
|
| D011471 | C065299 | Prostatic Neoplasms |
therapeutic
|
17155983
|
|
| D011658 | C065299 | Pulmonary Fibrosis |
therapeutic
|
16614485
|
|
| D001745 | C065299 | Urinary Bladder Diseases |
therapeutic
|
18786597
|